Home » Newsletters » BioWorld Science

BioWorld Science

May 10, 2007

View Archived Issues

Recent patents impart new therapeutic agents for cancer

Recent patents disclose new agents for metabolic disorders

Novel treatment option for respiratory disorders claimed in recent Argenta patent

MEND-CABG II study of MC-1 recommended to continue

CollaGenex discontinues 40 mg cohort in phase II acne study of incyclinide

COSTAR II study fails to meet endpoints

New data indicate Homspera may demonstrate adjuvant capabilities

TorreyPines to sell assets for treating autoimmune diseases to CalciMedica

New bioavailability data for BEMA Fentanyl

Australian TGA accepts Solbec's development plan for Coramsine

Interim three-month data for ISA-247 kidney transplant trial

Preliminary phase IIa data indicate utility of AT-1001 in celiac disease

New data on NX-1207 show sustained symptomatic improvement in BPH

AEterna Zentaris updates clinical progress

European CHMP recommends approval of Siklos

TRPV1 channel as a novel drug target in ocular disorders

Recent clinical data on intravitreal bevacizumab in ophthalmological conditions

Calcineurin inhibitor-free regimen with CP-690550 effective in renal transplantation

Studies show efficacy of lamotrigine in epilepsy

Abatacept associated with reduced flare incidence in juvenile idiopathic arthritis

Vision maintained with combretastatin A-4 in choroidal neovascularization patients

SRI International regains rights to tirapazamine from sanofi-aventis

Omrix seeks Swedish approval for HBIG product

New licensing agreement for NM-702 for arteriosclerosis obliterans

AEterna Zentaris regains rights for cetrorelix from Solvay

Fabre-Kramer amends NDA for gepirone ER in major depressive disorder

Adverse event reported in phase II anemia trial of FG-2216

PAC-113 active in the treatment of oral Candida infection

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...